Equities

EBR Systems Inc

EBR Systems Inc

Actions
Health CareMedical Equipment and Services
  • Price (AUD)1.08
  • Today's Change0.035 / 3.37%
  • Shares traded101.07k
  • 1 Year change+9.14%
  • Beta--
Data delayed at least 20 minutes, as of Jun 17 2024 06:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

EBR Systems, Inc. is engaged in the treatment for patients suffering from cardiac rhythm diseases by providing physiological stimulation through endocardiac pacing. The Company is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The Company also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The Company operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.

  • Revenue in AUD (TTM)0.00
  • Net income in AUD-52.81m
  • Incorporated2003
  • Employees--
  • Location
    EBR Systems Inc480 Oakmead ParkwaySUNNYVALE 94085United StatesUSA
  • Phone+1 (408) 720-1906
  • Fax+1 (408) 720-1996
  • Websitehttps://ebrsystemsinc.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Orthocell Ltd6.06m-7.42m77.45m----33.85--12.79-0.0369-0.03690.03010.01090.21821.5027.68---26.73-32.67-31.96-38.5377.1163.04-122.55-374.464.36--0.2586--215.2451.5331.39--11.07--
Imricor Medical Systems Inc927.76k-34.10m89.26m--------96.21-0.2167-0.21670.0059-0.07810.05590.87492.38---205.60-93.47-294.49-106.30-181.27-134.71-3,675.60-2,462.890.4944-3.6415.92---24.56-9.29-30.36---10.82--
SDI Ltd109.61m8.04m93.90m300.0011.681.057.610.85670.06760.06760.92210.74940.84491.696.22--6.207.277.468.4059.2859.797.348.071.2610.370.231851.8513.357.67-3.094.5052.585.39
ImpediMed Ltd10.47m-19.42m139.59m76.00--2.74--13.33-0.0102-0.01020.00550.02520.19611.324.41137,802.60-36.37-52.27-40.94-62.3486.9580.64-185.47-264.766.85--0.0244--7.3627.87-3.26--37.83--
Genetic Signatures Ltd16.49m-18.04m147.54m----3.11--8.94-0.1245-0.12450.11360.21720.33661.065.25---36.81-7.14-40.19-7.8240.6657.68-109.38-13.745.95-18,040.000.0003---38.1133.44-558.77--73.20--
Mach7 Technologies Ltd26.97m-5.55m156.81m90.00--2.8872.455.81-0.0231-0.02310.11230.22560.3605--3.21---7.42-7.48-8.73-8.6595.0993.72-20.59-20.56---2,605.170.0193--10.9728.3074.85--29.28--
EMvision Medical Devices Ltd8.86m-3.22m163.16m----26.08--18.41-0.0449-0.04490.11860.07330.7954-------28.95-67.20-45.25-79.38-----36.40-175.99---35.200.3424--62.0870.4736.64------
Cyclopharm Limited32.21m-4.70m166.74m87.00--4.49--5.18-0.0508-0.05080.34760.34280.67481.114.13370,173.10-9.85-12.60-11.92-14.9468.1570.20-14.60-25.472.32-18.400.1159--11.2215.5028.90---7.83-12.94
Aroa Biosurgery Ltd64.19m-9.88m215.13m261.00--2.44--3.35-0.0287-0.02870.18670.25640.6071.562.82---9.34-10.37-10.11-12.5285.3980.63-15.39-20.316.40--0.0726--9.0124.26-2,583.84--33.65--
4DMedical Ltd1.03m-30.83m244.62m----2.68--238.60-0.0882-0.08820.00290.23320.00980.0920.1585---29.47-43.96-39.07-57.5895.0032.30-3,007.64-2,704.361.79--0.0476---31.84-1.86-27.92--2.46--
EBR Systems Inc0.00-52.81m320.41m----6.82-----0.1823-0.18230.000.15250.00-------46.54---50.70-------------28.660.5609-------5.89------
Anteris Technologies Ltd7.03m-67.33m383.49m1.00--12.43--54.57-4.30-4.300.45031.610.20322.726.69---199.17-120.86-288.53-189.2777.3266.40-980.31-316.852.55-52.000.0804--4.48-22.85-51.86--42.27--
Paragon Care Ltd.317.39m10.31m686.95m0.0027.181.1031.122.160.01530.01240.46980.37590.68063.008.84--2.54-1.783.32-2.3340.9239.553.73-2.580.71213.040.374--29.5521.27111.05-1.5426.29-17.29
Data as of Jun 17 2024. Currency figures normalised to EBR Systems Inc's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.